AZIS R. DABAS
Explore
Contact
← InsightsPUBLISHED ANALYSIS
Insight / Operator brief

Prior Authorization Is Becoming API Infrastructure

Editorial revision: . Original publication and source dates are retained.

Five floating mineral forms connected by a continuous web of fine strands
Many systems. One purpose.Networks & operating systems

CMS interoperability policy changes the buying criteria for prior authorization. Vendors must connect API implementation to complete requests, visible decisions, reliable exception handling and measurable relief for provider teams.

Return to insights

Healthtech founders, payer strategy leaders, provider operations teams, and interoperability builders. / 2026-05-26

By Healthcare strategy and operating executive

The strategic question

What changes when prior authorization stops being a back-office pain point and becomes an API, metrics, and workflow-infrastructure market?

Public factsOperator interpretationBuyer implicationsFounder action

Anchored in public CMS policy and implementation guidance; no private payer strategy or account targeting is exposed.

Executive thesis

Source-backed operator read.

API implementation creates connectivity; it does not establish a complete authorization service. My investment thesis is that value accrues where requirements, evidence and decisions remain coherent across payer and provider systems, including the exceptions that cannot be resolved electronically.

Public facts

  1. The 2024 CMS Interoperability and Prior Authorization Final Rule requires impacted payers to implement several FHIR APIs, with many API requirements beginning January 1, 2027.

  2. CMS describes a Prior Authorization API that can identify documentation requirements and support prior authorization request and response workflows.

  3. CMS guidance also requires certain prior authorization metrics to be publicly reported, creating a measurement layer around the workflow.

  4. In April 2026, CMS proposed extending interoperability and prior authorization standards to drugs covered under medical and pharmacy benefits.

Operator read

  1. Policy deadlines make implementation readiness a buying criterion. The vendor must show how it meets the applicable requirements, fits existing workflows and measures the resulting burden reduction.

  2. The strongest product architecture connects request creation, documentation quality, payer response, denial reason, status visibility, and escalation.

  3. The strongest commercial architecture connects payer compliance pressure with provider burden relief and CFO-visible productivity.

Operating model

Separate compliance cost from workflow value.

I would separate the mandatory compliance investment from the discretionary workflow investment. The former is scoped against the requirements applicable to the payer and service. The latter must demonstrate an additional operating benefit: fewer incomplete submissions, less duplicate work, clearer status or more timely appropriate care. A vendor should explain both budgets without counting the same saving twice.

The economic risk is displacement of work. An electronic request can be fast to transmit while leaving clinical evidence assembly, reconciliation and follow-up unchanged. A payer may reduce telephone handling while a provider absorbs more documentation tasks. I would measure staff effort and unresolved cases on both sides, with patient delay tracked separately. A successful transport event is not a clinically or administratively resolved request.

Exception design will determine whether the infrastructure remains usable at scale. Missing documentation, inconsistent identifiers, changing policy and ambiguous responses require an accountable route back to the right team. The contract should specify status meaning, responsibility for correction and the ability to reconstruct what information supported a determination. AI may assist evidence preparation; the authority to make or challenge a consequential decision must remain explicit.

I would stage expansion by payer, service and request type. Begin where the requirements are well understood and the receiving workflow can resolve exceptions, then test whether the observed benefit survives a more complex mix. The next deployment should be justified by completed requests and total work removed, with implementation and maintenance costs included—not by the number of endpoints connected.

Operating framework

  1. 01

    Identify the impacted payers, required APIs and applicable compliance dates.

  2. 02

    Map documentation requirements, submission, response, denial reasons and exception handling as one request pathway.

  3. 03

    Measure decision time, status calls avoided, rework, provider burden and appeal quality.

  4. 04

    Agree on an implementation plan across payer operations, provider operations, compliance, product and finance.

Metrics that matter

  1. 01

    Authorization decision cycle time

  2. 02

    Manual touch and status-call reduction

  3. 03

    Request completeness and rework rate

  4. 04

    Provider abrasion and appeal patterns

  5. 05

    Publicly reported prior authorization metrics

Buyer implications

  1. Payers need implementation partners that reduce operational risk while meeting interoperability requirements.

  2. Providers need workflow relief that does not replace one queue with another.

  3. Healthtech founders need to show measurable burden reduction, not only standards alignment.

Founder actions

  1. Build the workflow map around the API: requirement discovery, submission, response, denial reason, escalation, and reporting.

  2. Create proof assets for timeframes, request completeness, rework, and provider abrasion.

  3. Make human review and exception handling visible in the product and the sales narrative.

  4. Connect prior authorization infrastructure to payer strategy, provider enablement, and RCM governance.

Red flags

  1. The pitch treats FHIR compliance as the value proposition instead of the starting point.

  2. The implementation story ignores provider workflow and exception handling.

  3. The product cannot explain denial reasons, human review, or audit trails.

CEO and CFO questions

  1. Which payer requirements become buying criteria by 2026 and 2027?

  2. What operating proof will show that the API reduced real burden?

  3. Where should AI assist the workflow without becoming an opaque gate to care?

Make expansion contingent on completed requests, reliable review and a measured reduction in the work required from payer and provider teams.

Map the prior authorization operating layer

Discuss the strategic decision

Which decision should the evidence change?

Discuss an operating mandate

FROM EVIDENCE TO EXECUTIVE ACTION

What would this change in your organization?